• Main Image Navi

QIAGEN Key Figures As of December 31

$1,000 except per share data 2016 2015 2014 2013 2012
Results
Net Sales 1,337,991 1,280,986 1,344,777 1,301,984 1,254,456
Operating Income 98,827 179,498 161,693 57,477 165,810
Net income* 80,404 130,148 116,365 64,624 126,642
Basic earnings per share (EPS)* 0.34 0.56 0.50 0.28 0.54
Diluted earnings per share (EPS)* 0.34 0.55 0.48 0.27 0.52
Number of shares (in thousands)
Weighted average number of common shares used to compute basic net income per common share 234,800 233,483 232,644 234,000 235,582
Weighted average number of common shares used to compute diluted net income per common share 238,993 238,647 242,806 243,400 242,020
Cash flow
Cash flow from operations 341,602 317,497 287,965 258,957 244,880
Capital expenditures for property, plant and equipment 74,536 97,778 86,591 84,468 101,996
Free cash flow(cash flow from operations less capital expenditures) 267,066 219,719 201,374 174,489 142,884
Balance sheet
Total assets 4,308,194 4,179,117 4,454,372 4,088,392 4,087,631
Cash and cash equivalents 439,180 290,011 392,667 330,303 394,037
Total long-term liabilities, including current portion 1,393,668 1,343,616 1,490,114 1,024,389 1,094,934
Total equity 2,607,096 2,568,070 2,664,876 2,731,891 2,730,979

* Attributable to the owners of QIAGEN N.V.